Cardiometabolic Drugs Market Set to Soar from USD 64.8 Billion in 2025 to USD 111.7 Billion by 2035, Driven by Lifestyle Diseases and Therapeutic Innovation
The global Cardiometabolic Drugs Market is on a robust growth trajectory, projected to expand from